Who can participate?
Children age 6–18 months with the full mutation may be eligible to participate.
What will happen in the study?
If the individual qualifies and decides to be in this research study, they will complete research activities at home for three sets of activities over the next year. The following is a list of some of the assessments that will happen during the study:
- Online surveys
- Phone interviews
- Telehealth-based play sessions
- Day-long audio recordings of your child’s vocalizations
- Sharing diagnostic records
What are the good things that can happen from this research?
Development of a new telehealth-based platform for remotely monitoring early clinical risk factors in rare syndromes.
What are the bad things that can happen from this research?
Risks include fussiness during the telehealth session, skin irritation or reddening from heart rate monitor adhesive (similar to a band aid), and potential loss of confidentiality. You are welcome to take as many breaks as needed during the telehealth session, or opt out of any tasks. All data is stored in secure, HIPAA-compliant locations, and is deidentified when possible. All researchers accessing your data have been trained to handle sensitive information.
There may be other risks that we do not know about yet.
Will you/your child be paid to complete this survey?
Participants receive $55 per round of assessment activities. You will also receive a brief developmental snapshot report of your child’s behavior as observed during the study.
Our Most Recent Opportunities
A Mount Sinai Genetic Counseling graduate student is conducting a research study to learn about possible benefits and side effects of CBD supplements when used to treat FXS symptoms. This information will be obtained by using an anonymous online parental and caregiver survey. About the Survey Who can participate? Parents and caregivers caring for somebody with FXS who uses, or has used, CBD supplements may be eligible to participate. The parent or caregiver responding to the survey must be at least 18 years old. The individual with »
Researchers at Teachers College at Columbia University are conducting a survey to learn about the impact that the COVID-19 pandemic has had on multiple aspects of the lives of people with Fragile X Syndrome. We want to see how the Fragile X community specifically was impacted so that we can have a more focused plan of action for helping these families. The overall goal of this survey is to distribute our findings to medical professionals so that they can see what gaps have been created in their practices from the pandemic.
Participants of this study will explore what information is considered most important to recently diagnosed fragile X premutation carriers. Open to premutation carriers 18 and over who were diagnosed sometime since January 2018.
Kaylynn Shuleski, a master’s in genetic counseling candidate, is conducting a research study to explore the concerns and challenges caregivers may face when planning long-term supports and living arrangements for their adult children with Fragile X syndrome (FXS). This information will be valuable for current and future families when considering long-term supports, as well as for healthcare professionals, counselors, and policy makers. About the Study Who can participate? Parents and caregivers of adults with full mutation »
Males between the ages of 18 and 30 years with a diagnosis of Fragile X syndrome (full mutation) may be eligible to participate.
The Research in Neurodevelopmental Disabilities Lab at the Waisman Center at the University of Wisconsin-Madison is looking for parents of male or female children 6 to 17 years old with Fragile X syndrome for an online survey.